CLINICAL_TRIALS
withdrawal
· 2016-01-01
Clinical Trial Update: Intraventricular Transplantation of Mesenchymal Stem Cell in Patients With ALS [Phase 1]
Summary
A phase 1 trial evaluating intraventricular transplantation of mesenchymal stem cells in patients with amyotrophic lateral sclerosis was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Royan Institute | Conditions: Amyotrophic Lateral Sclerosis | Phase 1 | Status: WITHDRAWN